210 related articles for article (PubMed ID: 25269805)
1. Impact of G-quadruplex structures and intronic polymorphisms rs17878362 and rs1642785 on basal and ionizing radiation-induced expression of alternative p53 transcripts.
Perriaud L; Marcel V; Sagne C; Favaudon V; Guédin A; De Rache A; Guetta C; Hamon F; Teulade-Fichou MP; Hainaut P; Mergny JL; Hall J
Carcinogenesis; 2014 Dec; 35(12):2706-15. PubMed ID: 25269805
[TBL] [Abstract][Full Text] [Related]
2. G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms.
Marcel V; Tran PL; Sagne C; Martel-Planche G; Vaslin L; Teulade-Fichou MP; Hall J; Mergny JL; Hainaut P; Van Dyck E
Carcinogenesis; 2011 Mar; 32(3):271-8. PubMed ID: 21112961
[TBL] [Abstract][Full Text] [Related]
3. The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcome.
Morten BC; Wong-Brown MW; Scott RJ; Avery-Kiejda KA
Carcinogenesis; 2016 Jan; 37(1):81-86. PubMed ID: 26586794
[TBL] [Abstract][Full Text] [Related]
4. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
[TBL] [Abstract][Full Text] [Related]
5. Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures.
Sagne C; Marcel V; Bota M; Martel-Planche G; Nobrega A; Palmero EI; Perriaud L; Boniol M; Vagner S; Cox DG; Chan CS; Mergny JL; Olivier M; Ashton-Prolla P; Hall J; Hainaut P; Achatz MI
Carcinogenesis; 2014 Apr; 35(4):807-15. PubMed ID: 24336192
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species.
Jurado J; Fuentes-Almagro CA; Prieto-Alamo MJ; Pueyo C
BMC Mol Biol; 2007 Sep; 8():83. PubMed ID: 17888145
[TBL] [Abstract][Full Text] [Related]
8. The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer.
Morten BC; Chiu S; Oldmeadow C; Lubinski J; Scott RJ; Avery-Kiejda KA
Breast Cancer Res Treat; 2019 Feb; 173(3):727-733. PubMed ID: 30430302
[TBL] [Abstract][Full Text] [Related]
9. Overlapping region of p53/wrap53 transcripts: mutational analysis and sequence similarity with microRNA-4732-5p.
Pouladi N; Kouhsari SM; Feizi MH; Gavgani RR; Azarfam P
Asian Pac J Cancer Prev; 2013; 14(6):3503-7. PubMed ID: 23886136
[TBL] [Abstract][Full Text] [Related]
10. Dual effect of a single nucleotide polymorphism in the first intron of the porcine secreted phosphoprotein 1 gene: allele-specific binding of C/EBP beta and activation of aberrant splicing.
Muráni E; Ponsuksili S; Seyfert HM; Shi X; Wimmers K
BMC Mol Biol; 2009 Oct; 10():96. PubMed ID: 19845957
[TBL] [Abstract][Full Text] [Related]
11. Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley.
Malik MA; Sharma K; Goel S; Zargar SA; Mittal B
Oncol Res; 2011; 19(3-4):165-9. PubMed ID: 21473292
[TBL] [Abstract][Full Text] [Related]
12. The G-Quadruplex-Specific RNA Helicase DHX36 Regulates p53 Pre-mRNA 3'-End Processing Following UV-Induced DNA Damage.
Newman M; Sfaxi R; Saha A; Monchaud D; Teulade-Fichou MP; Vagner S
J Mol Biol; 2017 Oct; 429(21):3121-3131. PubMed ID: 27940037
[TBL] [Abstract][Full Text] [Related]
13. Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53.
Hafsi H; Santos-Silva D; Courtois-Cox S; Hainaut P
BMC Cancer; 2013 Mar; 13():134. PubMed ID: 23514281
[TBL] [Abstract][Full Text] [Related]
14. Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene.
Laverdière M; Beaudoin J; Lavigueur A
Nucleic Acids Res; 2000 Mar; 28(6):1489-97. PubMed ID: 10684946
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects.
Sagne C; Marcel V; Amadou A; Hainaut P; Olivier M; Hall J
Cell Death Dis; 2013 Feb; 4(2):e492. PubMed ID: 23412385
[TBL] [Abstract][Full Text] [Related]
16. p53 isoforms can regulate p53 transcriptional activity.
Bourdon JC; Fernandes K; Murray-Zmijewski F; Liu G; Diot A; Xirodimas DP; Saville MK; Lane DP
Genes Dev; 2005 Sep; 19(18):2122-37. PubMed ID: 16131611
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
Hayes GM; Dougherty ST; Davis PD; Dougherty GJ
Cancer Gene Ther; 2004 Dec; 11(12):797-807. PubMed ID: 15359288
[TBL] [Abstract][Full Text] [Related]
18. Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53.
Will K; Warnecke G; Bergmann S; Deppert W
Nucleic Acids Res; 1995 Oct; 23(20):4023-8. PubMed ID: 7479059
[TBL] [Abstract][Full Text] [Related]
19. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
Yin CM; Yao YF; Yan ZL; Yang HY
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
